BBHC
Brown Brothers Harriman & Co Portfolio holdings
AUM
$15.6B
1-Year Return
17.71%
This Quarter Return
+3.25%
1 Year Return
+17.71%
3 Year Return
+77.24%
5 Year Return
+124.29%
10 Year Return
+261.89%
AUM
$15B
AUM Growth
-$85.2M
(-0.57%)
Cap. Flow
-$504M
Cap. Flow
% of AUM
-3.37%
Top 10 Holdings %
Top 10 Hldgs %
44.71%
Holding
1,359
New
175
Increased
426
Reduced
227
Closed
94
Top Buys
| 1 |
Arthur J. Gallagher & Co
AJG
|
+$344M |
| 2 |
A.O. Smith
AOS
|
+$224M |
| 3 |
Booking.com
BKNG
|
+$169M |
| 4 |
Alcon
ALC
|
+$104M |
| 5 |
Bright Horizons
BFAM
|
+$102M |
Top Sells
| 1 |
Wells Fargo
WFC
|
+$413M |
| 2 |
Sabre
SABR
|
+$321M |
| 3 |
Kroger
KR
|
+$239M |
| 4 |
PayPal
PYPL
|
+$213M |
| 5 |
Novartis
NVS
|
+$105M |
Sector Composition
| 1 | Financials | 18.31% |
| 2 | Technology | 14.58% |
| 3 | Industrials | 13.7% |
| 4 | Consumer Staples | 13.01% |
| 5 | Healthcare | 13.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRCL
276
DELISTED
Stericycle Inc
SRCL
| $565K | ﹤0.01% |
11,101
+251
| +2% | +$12.8K |
|
277
Invesco QQQ Trust
QQQ
$371B
| $559K | ﹤0.01% |
2,961
+1,190
| +67% | +$225K |
|
278
Constellation Brands
STZ
$25.2B
| $559K | ﹤0.01% |
2,696
+2,223
| +470% | +$461K |
|
279
Cummins
CMI
$56.6B
| $546K | ﹤0.01% |
3,358
-781
| -19% | -$127K |
|
|
NLSN
280
DELISTED
Nielsen Holdings plc
NLSN
| $533K | ﹤0.01% |
25,081
-5,140
| -17% | -$109K |
|
281
Aptiv
APTV
$18.2B
| $529K | ﹤0.01% |
6,053
+2,279
| +60% | +$199K |
|
282
Crown Castle
CCI
$41.6B
| $529K | ﹤0.01% |
3,805
-711
| -16% | -$98.8K |
|
283
ProShares Short S&P500
SH
$1.22B
| $523K | ﹤0.01% |
5,000
| – | – |
|
284
Vanguard High Dividend Yield ETF
VYM
$65.3B
| $523K | ﹤0.01% |
5,899
+1,654
| +39% | +$147K |
|
285
Hamilton Lane
HLNE
$6.75B
| $521K | ﹤0.01% |
9,143
-19,169
| -68% | -$1.09M |
|
286
Labcorp
LH
$23.2B
| $520K | ﹤0.01% |
3,600
+3,278
| +1,018% | +$473K |
|
287
Clorox
CLX
$15.2B
| $518K | ﹤0.01% |
3,412
+18
| +0.5% | +$2.73K |
|
288
Autodesk
ADSK
$69.1B
| $517K | ﹤0.01% |
3,498
+2,894
| +479% | +$428K |
|
289
Vanguard S&P 500 ETF
VOO
$740B
| $507K | ﹤0.01% |
1,861
+721
| +63% | +$196K |
|
|
AGN
290
DELISTED
Allergan plc
AGN
| $506K | ﹤0.01% |
3,009
+227
| +8% | +$38.2K |
|
291
Okta
OKTA
$16.2B
| $504K | ﹤0.01% |
5,117
| – | – |
|
292
Mettler-Toledo International
MTD
$26.4B
| $502K | ﹤0.01% |
713
+70
| +11% | +$49.3K |
|
293
Bank of New York Mellon
BK
$74.5B
| $490K | ﹤0.01% |
10,849
+1,433
| +15% | +$64.7K |
|
294
Vanguard FTSE Europe ETF
VGK
$27.2B
| $490K | ﹤0.01% |
9,136
+3,616
| +66% | +$194K |
|
295
International Paper
IP
$24.6B
| $485K | ﹤0.01% |
12,253
-1,282
| -9% | -$50.7K |
|
296
M&T Bank
MTB
$30.9B
| $481K | ﹤0.01% |
3,047
+17
| +0.6% | +$2.68K |
|
297
Brown-Forman Class A
BF.A
$13.3B
| $480K | ﹤0.01% |
8,040
| – | – |
|
298
KKR & Co
KKR
$129B
| $479K | ﹤0.01% |
17,850
| – | – |
|
299
GATX Corp
GATX
$6.11B
| $473K | ﹤0.01% |
+6,101
| New | +$473K |
|
300
Novo Nordisk
NVO
$241B
| $473K | ﹤0.01% |
18,306
+2,734
| +18% | +$70.6K |
|